Alison Button-Sloan
@AButtonSloan
Followers
511
Following
5K
Media
43
Statuses
901
RN/DiabEdu | National advocate and consumer consultant for #melanoma patients and clinicians|scientists|research | Own opinions
Melbourne
Joined May 2012
It’s always a pleasure to catch up with friends & everyone at Parkrun (5k walk/run on Saturdays). It was fun catching up with The Guardian’s Kate Lyons recently too! https://t.co/FfjBnkqcaM
@GuardianAustral
@parkrunAU
@SydneyLHD
@Sydney_Uni
@AllenAndUnwin
@gmaddox
16
46
578
🗣 Session 2, "Consumer Forum", focussed on providing our wonderful consumers w/ updates on our cohort study presented by Dr Uyen Koh and the use of AI in skin cancer detection by @DrVictoriaMar. The session ended with an interactive Q&A/poll presented by @AButtonSloan 📊
🌟 Day 2 of the ACEMID Researcher Workshop 2025 started off w/ a "Melanographer session", in which @PabloFP_Syd highlighted positive and constructive feedback from our Melanographers who conduct the study visits 📷🔎, and developed future action points to improve our work!
0
2
7
🚨PhD Opportunity 🚨 Join ACRF ACEMID & @UQ_CHSR to work on the largest melanoma cohort study!🌏 Under Professor @MonikaJanda's supervision, you'll develop a roadmap for melanoma screening in regional Australia🔎🇦🇺 🔗More info & apply now: https://t.co/qpikBG83ys
0
4
6
🎉 Recruitment milestone! ACERF ACEMID has reached 50% of its recruitment target with 7,548 participants enrolled, who have over 17,255 study visits completed across 15 active sites. A huge thanks to all for the support and dedication! 🌟 @UQ_News @MonashUni @Sydney_Uni
0
2
7
Interesting paper.
When to stop immunotherapy for advanced melanoma: the emulated target trials
0
0
0
Despite saying he’s all for sun safety, Nic’s comment says it all ‘not if it’s going to ruin my tan’. ⬇️ What a great role model for people under 40y - NOT. According to our Austs of the Year @ProfGLongMIA & @ProfRAScolyer, #melanoma experts, there’s nothing healthy about a tan.
Aussies have been left outraged after beachgoers were caught using their cabanas to snag spots on popular beaches. Nic Salerno has been on a crusade against Cabanas, and he tells us why he is so against them.
0
0
1
Proud of us Aussies, taking up sun safety message & raising awareness at ‘Parliamentary Friends of Melanoma & Skin Cancer Awareness’ BBQ with melanoma nurses representation (project lead Rebecca Johnson), wonderful advocacy teams across Australia & parliamentarians incl
0
4
33
Thank you to the @eurekaprizes for featuring ACEMID in your blog. “This accolade not only brings visibility to our work but also provides a platform to further advocate for advancements in skin cancer prevention and early detection” https://t.co/IEZEI88dkv
australian.museum
Drawing from a multidisciplinary team, these Eureka Prize winners utilise AI-assisted 3D imaging technologies to conduct the world's largest preventive melanoma study.
0
3
7
Great evening!
@melanoma_MRV held its annual public forum last night. Always good to hear the about the year's achievements from research @McArthurGrant and consumer @AButtonSloan perspectives.
0
0
3
If George Washington was the father of America’s democracy, Donald Trump is its undertaker https://t.co/bEOPWF8QDE
apple.news
When Joe Biden took power, he said he would try to save American democracy. He and Kamala Harris have failed.
0
0
0
Join us for MRV’s Annual Scientific Exchange Meeting on Thurs, Nov 7, hosted by Prof. Grant McArthur at Peter MacCallum Cancer Centre. In-person or online ✨MRV updates ⚖️ Debate: "No future role for adjuvant therapy?" 🤖 AI & histopathology in melanoma Plus more: see agenda⬇️
MRV's annual Scientific Exchange Meeting is on this Thursday 7th November. All welcome. Hope to see you in person or online. Register here:
0
0
3
It was fantastic to bring our ACEMID team together in Sydney last week for the ACEMID researcher workshop, diving into the IMAGE trial and our work in genetics, pathology, and biomarkers 🔬🧬
0
4
13
One of the many highlights of #AMC2024 was meeting @JeffGershenwald, Chair of the 8th Edn AJCC Melanoma Staging Panel!
0
0
7
As @AMSCA_Mel Chair, it was a fabulous opportunity to showcase the achievements of our 11 melanoma & skin cancer Alliance member organisations at #AMC2024. But, to discover the hidden dramatic arts talents of our consumers during the debate in the same session was priceless!
Day 1 of #AMC2024 wrapped up with a lively debate: 'Patient advocacy & consumer representation are just a tick box exercise'. Very entertaining, with academy-award worthy role play! The negative team won, confirming consumer input is NOT simply a tick-the-box exercise.
0
0
5
Having attended & presented at many midwifery, nursing, diabetes conferences over the years, this year’s #AMC2024 would have to rank as #1. Congratulations @MelanomaAus
During #AMC2024 opening @ProfGLongMIA & @ProfRScolyerMIA reflected on how the melanoma landscape has changed & the roadmap to reach zero deaths from melanoma, including consistent sun smart messaging, national targeted skin cancer screening, advancing treatment & supportive care.
0
1
14
One of the many brilliant sessions at the #AMC2024.
Inspiring #AMC2024 discussions: 'Overview of peri-operative systemic therapies'- neodjuvant therapy, histopathology & surgery considerations, personalised vaccines, clinical stage II & III melanoma @amenzies9 @Robbotommo @davidgyorki @inespiresilva #VictoriaAtkinson #RobertRawson
0
0
2
Is there still a role for sentinel lymph node biopsy in the modern melanoma era for clinical stage IIB/C ? Prof. Andrew Barbour’s brilliant talk reminds us that YES, there is! #Togetheramplifyingtheimpact #MelanomaCare #CancerResearch #AMC2024 @MelanomaAus @TRI_info
0
3
7
'Skin checks in primary care: Best practice & future directions'. Insightful session at #AMC2024 covering challenges of skin checks, risk prediction tools, integrating new technologies for surveillance & supportive care needs of patients. @AnneECust
1
1
8
Fantastic poster from the @Melanoma_MRV team show casing how #melanoma patients research priorities have changed over ten years with the advent of the targeted and immunotherapies.
0
0
0